VANGUARD GROUP INC - F-STAR THERAPEUTICS INC ownership

F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 22 filers reported holding F-STAR THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of F-STAR THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,849,636
+15.6%
292,664
-6.4%
0.00%
Q3 2022$1,600,000
-71.3%
312,608
-64.8%
0.00%
Q2 2022$5,566,000
+162.1%
889,253
+48.6%
0.00%
Q1 2022$2,124,000
-43.4%
598,437
-20.0%
0.00%
Q4 2021$3,754,000
-31.1%
747,700
+0.4%
0.00%
Q3 2021$5,451,000
-17.9%
744,623
-3.7%
0.00%
Q2 2021$6,642,000
+16.1%
773,215
+46.3%
0.00%
Q1 2021$5,723,000
+49.4%
528,489
+36.2%
0.00%
Q4 2020$3,830,000388,0480.00%
Other shareholders
F-STAR THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Advisors, Inc. 574,996$2,944,0001.06%
AlphaCentric Advisors LLC 165,000$845,0000.87%
DAFNA Capital Management LLC 576,881$2,954,0000.80%
Knott David M Jr 235,945$1,208,0000.51%
Atlas Venture Life Science Advisors, LLC 599,524$3,070,0000.34%
S. MUOIO & CO. LLC 40,000$205,0000.27%
Murchinson Ltd. 162,624$833,0000.24%
Connolly Sarah T. 53,001$271,0000.20%
BCK CAPITAL MANAGEMENT LP 52,000$266,0000.19%
Diametric Capital, LP 44,449$228,0000.12%
View complete list of F-STAR THERAPEUTICS INC shareholders